Literature DB >> 31662540

The Predictive Value of the CRP-to-Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study.

Jovan Vujic1, Katharina Marsoner1, Valerie Wienerroither1, Hans-Jorg Mischinger1, Peter Kornprat2.   

Abstract

BACKGROUND/AIM: Prognostic factors like the CRP-to-albumin ratio (CAR) represent potential predictors for survival of pancreatic cancer patients. We aimed to investigate the prognostic strength of the CAR for overall survival of patients with pancreatic cancer undergoing pancreatic resection. PATIENTS AND METHODS: Data from a total of 202 patients with pancreatic adenocarcinoma who had undergone curative pancreatic resection were subjected to a retrospective review. Overall survival was calculated according to the Kaplan-Meier method, and multivariate Cox regression analysis was used for calculating the prognostic strength of CAR.
RESULTS: CAR was an independent prognostic factor of overall survival in univariate and multivariate Cox regression analysis. Elevated CAR was associated with a higher median value of Charlson Index, higher Union for International Cancer Control (UICC) classification and increased carcinoembryonic antigen (CEA) levels.
CONCLUSION: CAR is a useful prognostic factor for the prediction of overall survival for patients undergoing pancreatic surgery. The impact of CAR in individual risk assessment should be evaluated in further studies. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C-reactive protein; CAR; albumin; pancreatic adenocarcinoma; surgery

Mesh:

Substances:

Year:  2019        PMID: 31662540      PMCID: PMC6899080          DOI: 10.21873/invivo.11706

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  26 in total

Review 1.  The role of inflammation in pancreatic cancer.

Authors:  Simone Hausmann; Bo Kong; Christoph Michalski; Mert Erkan; Helmut Friess
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

2.  Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark.

Authors:  Jakob Kirkegård; Deirdre Cronin-Fenton; Uffe Heide-Jørgensen; Frank Viborg Mortensen
Journal:  Gastroenterology       Date:  2018-02-09       Impact factor: 22.682

3.  Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.

Authors:  Shinichi Ikuta; Tsukasa Aihara; Naoki Yamanaka
Journal:  Asia Pac J Clin Oncol       Date:  2019-01-10       Impact factor: 2.601

4.  The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection.

Authors:  Koichiro Haruki; Hiroaki Shiba; Yoshihiro Shirai; Takashi Horiuchi; Ryota Iwase; Yuki Fujiwara; Kenei Furukawa; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  World J Surg       Date:  2016-09       Impact factor: 3.352

5.  The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nami Imai; Akira Iwaku; Mutumi Oishi; Ken Tanaka; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Masato Matsushima
Journal:  Ann Surg Oncol       Date:  2014-09-05       Impact factor: 5.344

6.  The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy.

Authors:  Min Hyung Kim; Jin Young Ahn; Je Eun Song; Heun Choi; Hea Won Ann; Jae Kyoung Kim; Jung Ho Kim; Yong Duk Jeon; Sun Bean Kim; Su Jin Jeong; Nam Su Ku; Sang Hoon Han; Young Goo Song; Jun Young Choi; Young Sam Kim; June Myung Kim
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

7.  Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients.

Authors:  Junjie Hang; Peng Xue; Haiyan Yang; Shaobo Li; Donghui Chen; Lifei Zhu; Weiyi Huang; Shujuan Ren; Yue Zhu; Liwei Wang
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

Review 8.  Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.

Authors:  Andrea Padoan; Mario Plebani; Daniela Basso
Journal:  Int J Mol Sci       Date:  2019-02-05       Impact factor: 5.923

9.  Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; W J Angerson; D J Dunlop
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

10.  Pancreatic ductal adenocarcinoma epidemiology and risk assessment: Could we prevent? Possibility for an early diagnosis.

Authors:  Noor L H Bekkali; Kofi W Oppong
Journal:  Endosc Ultrasound       Date:  2017-12       Impact factor: 5.628

View more
  2 in total

1.  Preoperative C-Reactive Protein/Albumin Ratio as a Predictive Factor for Gallbladder Carcinoma.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Megumi Watanabe; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.

Authors:  Qinfen Xie; Lidong Wang; Shusen Zheng
Journal:  Dose Response       Date:  2020-06-29       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.